Down-regulation of tumor suppressor a kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanisms

Hepatology

Volumn 52, Issue 6, 2010, Pages 2023-2033

  Goeppert, Benjamin ^a   Schmezer, Peter ^b   Dutruel, Céline ^b   Oakes, Christopher ^b   Renner, Marcus ^a   Breinig, Marco ^a   Warth, Arne ^a   Vogel, Monika Nadja ^c   Mittelbronn, Michel ^d   Mehrabi, Arianeb ^a   Gdynia, Georg ^a   Penzel, Roland ^a   Longerich, Thomas ^a   Breuhahn, Kai ^a   Popanda, Odilia ^b   Plass, Christoph ^b   Schirmacher, Peter ^a   Kern, Michael André ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; MESSENGER RNA; MICRORNA;

ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; GENE EXPRESSION; GENE LOSS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; METHYLATION; PRIORITY JOURNAL; PROMOTER REGION; TISSUE MICROARRAY; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

A KINASE ANCHOR PROTEINS; AZACITIDINE; CARCINOMA, HEPATOCELLULAR; CELL CYCLE PROTEINS; CELL LINE, TUMOR; DOWN-REGULATION; EPIGENESIS, GENETIC; HUMANS; LIVER NEOPLASMS; MICRORNAS; PROMOTER REGIONS, GENETIC; PROTEIN ARRAY ANALYSIS;

EID: 78649613036     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23939     Document Type: Article

References (27)

1. Beene DL, Scott JD. A-kinase anchoring proteins take shape. Curr Opin Cell Biol 2007; 19: 192-198.
2. Frisch SM. cAMP takes control. Nat Cell Biol 2000; 2: E167-E168.
3. Su B, Bu Y, Engelberg D, Gelman IH. SSeCKS/Gravin/AKAP12 inhibits cancer cell invasiveness and chemotaxis by suppressing a protein kinase C-Raf/MEK/ERK pathway. J Biol Chem 2010; 285: 4578-4586.
4. Kitisin K, Ganesan N, Tang Y, Jogunoori W, Volpe EA, Kim SS, et al. Disruption of transforming growth factor-beta signaling through beta-spectrin ELF leads to hepatocellular cancer through cyclin D1 activation. Oncogene 2007; 26: 7103-7110.
5. Yamamoto M, Tamakawa S, Yoshie M, Yaginuma Y, Ogawa K. Neoplastic hepatocyte growth associated with cyclin D1 redistribution from the cytoplasm to the nucleus in mouse hepatocarcinogenesis. Mol Carcinog 2006; 45: 901-913.
6. Akakura S, Huang C, Nelson PJ, Foster B, Gelman IH. Loss of the SSeCKS/Gravin/AKAP12 gene results in prostatic hyperplasia. Cancer Res 2008; 68: 5096-5103.
7. Su B, Zheng Q, Vaughan MM, Bu Y, Gelman IH. SSeCKS metastasis-suppressing activity in MatLyLu prostate cancer cells correlates with vascular endothelial growth factor inhibition. Cancer Res 2006; 66: 5599-5607.
8. Choi MC, Jong HS, Kim TY, Song SH, Lee DS, Lee JW, et al. AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity. Oncogene 2004; 23: 7095-7103.
9. Streb JW, Kitchen CM, Gelman IH, Miano JM. Multiple promoters direct expression of three AKAP12 isoforms with distinct subcellular and tissue distribution profiles. J Biol Chem 2004; 279: 56014-56023.
10. Schlaeger C, Longerich T, Schiller C, Bewerunge P, Mehrabi A, Toedt G, et al. Etiology-dependent molecular mechanisms in human hepatocarcinogenesis. HEPATOLOGY 2008; 47: 511-520.
11. Singer S, Ehemann V, Brauckhoff A, Keith M, Vreden S, Schirmacher P, et al. Protumorigenic overexpression of stathmin/Op18 by gain-of-function mutation in p53 in human hepatocarcinogenesis. HEPATOLOGY 2007; 46: 759-768.
12. Bressac B, Galvin KM, Liang TJ, Isselbacher KJ, Wands JR, Ozturk M. Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc Natl Acad Sci U S A 1990; 87: 1973-1977.
13. Tsuji T, Miyazaki M, Fushimi K, Mihara K, Inoue Y, Ohashi R, et al. Cyclin E overexpression responsible for growth of human hepatic tumors with p21WAF1/CIP1/SDI1. Biochem Biophys Res Commun 1998; 242: 317-321.
14. Nussler AK, Vergani G, Gollin SM, Dorko K, Morris SM Jr., Demetris AJ, et al. Isolation and characterization of a human hepatic epithelial-like cell line (AKN-1) from a normal liver. In Vitro Cell Dev Biol Anim 1999; 35: 190-197.
15. Pallasch CP, Patz M, Park YJ, Hagist S, Eggle D, Claus R, et al. miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia. Blood 2009; 114: 3255-3264.
16. Funke B, Autschbach F, Kim S, Lasitschka F, Strauch U, Rogler G, et al. Functional characterisation of decoy receptor 3 in Crohn's disease. Gut 2009; 58: 483-491.
17. Wiebalk K, Schmezer P, Kropp S, Chang-Claude J, Celebi O, Debus J, et al. In vitro radiation-induced expression of XPC mRNA as a possible biomarker for developing adverse reactions during radiotherapy. Int J Cancer 2007; 121: 2340-2345.
18. Wang Y, Lee AT, Ma JZ, Wang J, Ren J, Yang Y, et al. Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. J Biol Chem 2008; 283: 13205-13215.
19. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20.
20. Flotho C, Paulun A, Batz C, Niemeyer CM. AKAP12, a gene with tumour suppressor properties, is a target of promoter DNA methylation in childhood myeloid malignancies. Br J Haematol 2007; 138: 644-650.
21. Lin X, Nelson P, Gelman IH. SSeCKS, a major protein kinase C substrate with tumor suppressor activity, regulates G(1)-->S progression by controlling the expression and cellular compartmentalization of cyclin D. Mol Cell Biol 2000; 20: 7259-7272.
22. Calvisi DF, Ladu S, Gorden A, Farina M, Lee JS, Conner EA, et al. Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma. J Clin Invest 2007; 117: 2713-2722.
23. Tessema M, Willink R, Do K, Yu YY, Yu W, Machida EO, et al. Promoter methylation of genes in and around the candidate lung cancer susceptibility locus 6q23-25. Cancer Res 2008; 68: 1707-1714.
24. Iorio MV, Piovan C, Croce CM. Interplay between microRNAs and the epigenetic machinery: an intricate network. Biochim Biophys Acta 2010 May 20. Epub ahead of print.
25. Rombouts K, Knittel T, Machesky L, Braet F, Wielant A, Hellemans K, et al. Actin filament formation, reorganization and migration are impaired in hepatic stellate cells under influence of trichostatin A, a histone deacetylase inhibitor. J Hepatol 2002; 37: 788-796.
26. Bu Y, Gelman IH. v-Src-mediated down-regulation of SSeCKS metastasis suppressor gene promoter by the recruitment of HDAC1 into a USF1-Sp1-Sp3 complex. J Biol Chem 2007; 282: 26725-26739.
27. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003; 33( Suppl): 245-254.